OB Pharm Flashcards
Tocolytic Agents
Medications used to stop uterine contractions & delay preterm birth
Magnesium sulfate, Terbutaline, Indomethacin, Nifedipine
Criteria for Tocolytic Use
EGA between 20-34 weeks, documented preterm labor, maternal consent
Benefits: decreased neonatal M/M
Indications for Short Course Tocolytics
- facilitate transport from a small to larger hospital
- delay delivery for 24-48 hrs to allow use of corticosteroids to mature infant lungs
- neuroprotection for fetal brain
- fetal resuscitation in utero for a compromised fetus
Relative Contraindications for Tocolytic Therapy
- cervical dilation > 4 cm (labor is inevitable)
- ruptured membranes (increased risk of infection)
Absolute Contraindications for Tocolytic Therapy
- fetal death
- fetal anomalies incompatible with life
- fetal compromise warranting immediate delivery
- chorioamnionitis
- severe hemorrhage
- severe chronic HTN and/or preeclampsia
Magnesium Sulfate (Toco)
MOA –> inhibits release of acetylcholine in neuromuscular junctions; thought to provide neuroprotective effect decreasing the incidence & severity of CP in preterm infants
Route –> IV
Excreted by kidney
Dosing –> large initial dose & smaller maintenance dose
Therapeutic Mag Level –> 4-7.5 mg/dL
Magnesium Sulfate Maternal Adverse Effects
Non-life threatening: flushing, N/V, diplopia, blurred vision, headache, lethargy, burns IV site
Serious effects: muscle weakness, loss of DTRs, pulmonary edema, respiratory arrest, ileum, hypocalcemia, cardiac arrest
Magnesium Sulfate Fetal/Neonatal Side Effects
Hypotonia –> floppy newborn, decreased body tone
Lethargy
Hypocalcemia
Calcium Gluconate
Given to reverse effects of magnesium sulfate
- frequent monitoring of BP, P, R, LOC & DTRs until stable
- may require more than one dose if renal function is slow to clear Mag
Magnesium Sulfate Nursing Care
- Frequent VS (potential for decreased RR)
- Auscultate breath sounds q2 hours (potential for atelectasis or pulmonary edema)
- Continuous SaO2 monitoring
- DTRs q1-2 hr
- Continuous EFM (may depress fetal activity & decrease baseline FHR variability)
- Labs
- Bed rest (for patient safety)
- I&O q hr (assess for decreased UOP)
Terbutaline
Beta-Agonist
MOA –> promotes binding of intracellular calcium, which inhibits actin & myosin chain which results in relaxation of smooth muscle
Use –> used for intrauterine fetal resuscitation due to FHR prolonged deceleration, titanic uterine contraction & increased uterine resting tone
Dose – recommended SQ
Contraindications: cardiac disease, hyperthyroidism, DM, convulsive disorders
Terbutaline Maternal Adverse Effects
Metabolic: hyperglycemia, hypokalemia
Other: nervousness, N/V
CV: tachycardia, palpitations, hypotension, chest pain/myocardial ischemia, SOB/Pulmonary edema
Terbutaline Fetal/Neonatal Adverse Effects
Fetal: tachycardia, hyperinsulinemia, hyperglycemia
Neonatal: hypoglycemia, hypocalcemia, hypotension, ileus
Terbutaline Nursing Care
- Check VS (Hold if HR > 120 or BP < 90/60)
- Monitor for S/S of pulmonary edema (osculate breath sounds q4 hrs - check for dyspnea, coughing, crackles, wheezing, decreased SaO2)
- I&O (watch for oliguria)
- Assess fetal response (tachycardia)
Indomethacin
Prostaglandin Synthase Inhibitor
MOA –> NSAID; blocks production of prostaglandins leading to smooth muscle relaxation
Admin –> loading dose via rectum & PO dose with food; given over 72 hrs
Use –> only used prior to 32 weeks EGA (has a risk of closing the ductus arterioles prematurely)
Indomethacin Maternal Adverse Effects
- N/V
- Dizziness
- Skin rash
- Decreased renal blood flow
- Postpartum hemorrhage (if delivered close to time of delivery)
Indomethacin Neonatal Adverse Effects
- ventricular hypertrophy
- premature closure of the ductus arteriosus
- oligohydramnios (too little amniotic fluid due to decreased blood flow to the fetus)
Indomethacin Nursing Care
- I&O (potential for oliguria)
- Postpartum (be prepared for hemorrhage; medications, fundal massage)
Nifedipine
Calcium Channel Blocker
MOA –> relaxes smooth muscle by blocking calcium entry into the cell
Nifedipine Maternal Adverse Effects
- Hypotension
- Tachycardia
- Facial flushing
- Headache
- Peripheral edema
- Nausea
Nifedipine Neonatal Adverse Effects
No known adverse fetal effects
Betamethasone
Corticosteroid
MOA –> enhances fetal lung maturity by promoting increased synthesis & release of surfactant resulting in improved neonatal lung function & prevention of RDS
Admin –> injection into pregnant mom; 2 IM doses given 24 hours apart
Use –> recommended for women at 23-34 weeks EGA at risk for preterm delivery within 7 days
Surfactant
MOA –> synthetic lipoprotein used to decrease surface tension of the pulmonary fluids in the alveoli to decrease atelectasis
Admin –> given to preterm infant per ETT by NICU personnel to prevent/decrease RDS
Preeclampsia/Hypertension Medications
Anti-Seizure: Magnesium Sulfate
Antihypertensives: Hydrazine, Methyldopa, Labetalol
Magnesium Sulfate (PreE)
MOA –> unknown; thought to compete with intracellular calcium across cell membrane
Use –> prevent/treat eclamptic seizures in women with preeclampsia
Dosing –> large initial dose & smaller maintenance dose; different seizure dose treatment
Hydrazine Hydrochloride
Use –> HTN crisis
Admin –> IV push every 20 minutes until max dose is reached or BP controlled